VYNE Overview

U.S. Stock Market Performance: U.S. stocks declined mid-session, with the Nasdaq Composite dropping over 1%, while the Dow and S&P 500 also experienced losses. Energy shares rose by 1.3%, but information technology stocks fell by 1.8%.

General Mills Earnings Report: General Mills reported better-than-expected second-quarter earnings of $1.10 per share, surpassing analyst estimates, despite a 7% year-over-year decline in quarterly sales.

Notable Stock Movements: Vyne Therapeutics saw a 57% increase in shares after announcing a merger, while Udemy's shares surged 27% following a merger agreement with Coursera. Conversely, Vistagen Therapeutics shares plummeted 81% after failing to meet study endpoints.

Global Market Trends: European shares mostly rose, with the eurozone's STOXX 600 gaining 0.39%, while Asian markets closed higher, led by Japan's Nikkei and China's Shanghai Composite.

U.S. Stock Market Performance: U.S. stocks saw gains, with the Dow Jones rising approximately 150 points, while the NASDAQ and S&P 500 also experienced slight increases. Energy shares led the rise, up by 1%, while information technology stocks fell by 0.1%.

Earnings Reports: Jabil Inc reported better-than-expected earnings for its first quarter, with adjusted earnings of $2.85 per share, surpassing estimates. In contrast, Children's Place Inc faced a significant drop in shares following disappointing third-quarter results.

Notable Stock Movements: Vyne Therapeutics shares surged 66% after announcing a merger agreement, while Agape ATP Corp and Aditxt Inc also saw substantial increases in their stock prices. Conversely, Vistagen Therapeutics experienced a dramatic 79% drop after failing to meet study endpoints.

Global Market Trends: European shares were mixed, with the STOXX 600 gaining slightly, while Asian markets mostly closed higher, led by Japan and Hong Kong. Additionally, mortgage applications in the U.S. fell by 3.8% in the latest week.